Literature DB >> 14505105

Improved method for the intracerebral engraftment of tumour cells and intratumoural treatment using a guide screw system in mice.

M A Brockmann1, M Westphal, K Lamszus.   

Abstract

BACKGROUND: Orthotopic in vivo models for the experimental treatment of malignant gliomas have become indispensable to evaluate the efficacy of novel therapeutic regimens. Recently, a guide screw system was introduced which is implanted into the cranium of small rodents where it facilitates fast, repeated and exactly reproducible intracerebral injections, avoiding time consuming stereotactic procedures. Here we report our experience with this system, and describe several modifications which we introduced to improve its reliability and to simplify its application.
FINDINGS: The most important modification made was the optimization of the guide screw implantation site, which needs to be adapted to the age of the mice. Other improvements were the fixation of the guide screw to the cranium of the mice using a two component adhesive. This avoids the tendency, when daily intratumoural injections are performed over several weeks, for the screw to loosen, making precise injections impossible. The injection procedure, initially described as a free-hand approach, was improved by mounting the syringe to a Greenberg retractor. This provided additional stability and speeded up the process. Applying this modified technique, we were able to achieve reproducible results with regard to engraftment rate, tumour growth, and intratumoural treatment in immunocompromized mice.
INTERPRETATION: We introduced several major and some minor improvements to make working with the guide screw system more reliable, faster and more comfortable. Daily injections over a period of three weeks using this system are feasible and well tolerated by mice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14505105     DOI: 10.1007/s00701-003-0091-5

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  7 in total

1.  Oncogenic role of p53 is suppressed by si-RNA bicistronic construct of uPA, uPAR and cathepsin-B in meningiomas both in vitro and in vivo.

Authors:  Reshu Gupta; Venkateswara Rao Gogineni; Arun Kumar Nalla; Chandramu Chetty; Jeffrey D Klopfenstein; Andrew J Tsung; Sanjeeva Mohanam; Jasti S Rao
Journal:  Int J Oncol       Date:  2011-02-02       Impact factor: 5.650

Review 2.  Perspectives of cellular and molecular neurosurgery.

Authors:  Manfred Westphal; Peter McL Black
Journal:  J Neurooncol       Date:  2004-11       Impact factor: 4.130

3.  Inhibition of invasion-associated thromboxane synthase sensitizes experimental gliomas to gamma-radiation.

Authors:  Anne Katrin Schauff; Ella L Kim; Jan Leppert; Roger Nadrowitz; Robin Wuestenberg; Mark Alexander Brockmann; Alf Giese
Journal:  J Neurooncol       Date:  2008-09-30       Impact factor: 4.130

4.  Chloroquine activates the p53 pathway and induces apoptosis in human glioma cells.

Authors:  Ella L Kim; Robin Wüstenberg; Anne Rübsam; Christoph Schmitz-Salue; Gabriele Warnecke; Eva-Maria Bücker; Nadine Pettkus; Daniel Speidel; Veit Rohde; Walter Schulz-Schaeffer; Wolfgang Deppert; Alf Giese
Journal:  Neuro Oncol       Date:  2010-01-27       Impact factor: 12.300

5.  RNAi-mediated abrogation of cathepsin B and MMP-9 gene expression in a malignant meningioma cell line leads to decreased tumor growth, invasion and angiogenesis.

Authors:  Padmaja Tummalapalli; Daniel Spomar; Christopher S Gondi; William C Olivero; Meena Gujrati; Dzung H Dinh; Jasti S Rao
Journal:  Int J Oncol       Date:  2007-11       Impact factor: 5.650

6.  RNA interference-mediated targeting of urokinase plasminogen activator receptor and matrix metalloproteinase-9 gene expression in the IOMM-lee malignant meningioma cell line inhibits tumor growth, tumor cell invasion and angiogenesis.

Authors:  Padmaja Tummalapalli; Christopher S Gondi; Dzung H Dinh; Meena Gujrati; Jasti S Rao
Journal:  Int J Oncol       Date:  2007-07       Impact factor: 5.650

7.  RNA interference targeting survivin exerts antitumoral effects in vitro and in established glioma xenografts in vivo.

Authors:  Sandy Hendruschk; Ralf Wiedemuth; Achim Aigner; Katrin Töpfer; Marc Cartellieri; Daniel Martin; Matthias Kirsch; Chrysanthy Ikonomidou; Gabriele Schackert; Achim Temme
Journal:  Neuro Oncol       Date:  2011-07-25       Impact factor: 12.300

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.